Towa Pharmaceutical Co (JP:4553) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Towa Pharmaceutical Co. has revised its financial forecasts upward for the fiscal year ending March 31, 2025, driven by strong overseas sales and lower-than-expected R&D expenses. The company now expects significant increases in profits and earnings per share due to favorable foreign exchange gains and operational efficiency.
For further insights into JP:4553 stock, check out TipRanks’ Stock Analysis page.